On statistical analysis of embedding in binary markov chain

A polynomial algorithm for calculating a likelihood function under the fixed parameters is developed. Maximum likelihood estimators for parameters of em- bedding and transition matrix are constructed and analyzed

On some upper bounds for noncentral chi-square cdf

Some new upper bounds for noncentral chi-square cdf are derived from the basic symmetries of the multidimensional standard Gaussian distribution. The proposed new bounds have analytically simple form compared to analogues available in the literature, and may be useful both in theory and in applications: for proving inequalities related to noncentral chi-square cdf, and for bounding powers of Pearson's chi-squared test

On statistical hypotheses testing of embedding

The goal of this paper is to find out when we are able reliably to distinguish a random sequence that does not have an embedded random sequence from a sequence that has it

On statistical hypotheses testing of embedding

The goal of this paper is to find out when we are able reliably to distinguish a random sequence that does not have an embedded random sequence from a sequence that has it

Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

Aims The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation. Methods and results Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (inhospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, prehospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin. Conclusion The EORP NSTEMI Registry is an international, prospective registry of care and outcomes of patients treated for NSTEMI, which will provide unique insights into the contemporary management of hospitalised NSTEMI patients, compliance with ESC 2015 NSTEMI Guidelines, and identify potential barriers to optimal management of this common clinical presentation associated with significant morbidity and mortality